Acro Biomedical (ACBM) Beginning Cash Balance (2018 - 2019)
Acro Biomedical's quarterly Beginning Cash Balance came in at $50000.0 in Q4 2019, down 64.62% year-on-year from $141336.0 in Q4 2018, and up 11.11% quarter-over-quarter from $45000.0 in Q3 2019.
Acro Biomedical has reported Beginning Cash Balance for 2 years, with the latest figure at $50000.0 in Q4 2019.
- For the quarter ending Q4 2019, Beginning Cash Balance fell 64.62% year-over-year to $50000.0; the trailing twelve-month figure through Sep 2022 stood at $95000.0 (changed 0.0% YoY), and the FY2019 full-year result was $95001.0, changed N/A from the prior year.
- Beginning Cash Balance for Q4 2019 stood at $50000.0, up from $45000.0 in the prior quarter.
- The five-year high for Beginning Cash Balance was $141336.0 in Q4 2018, with the low at $45000.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 50,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Sep 30, 2019 | 45,000.00 |
| Sep 30, 2019 | 45,000.00 |
| Dec 31, 2018 | 141,336.00 |
| Dec 31, 2018 | 141,336.00 |